Cyclo Therapeutics, Inc.·4

Jan 19, 2:59 PM ET

FINE N SCOTT 4

4 · Cyclo Therapeutics, Inc. · Filed Jan 19, 2022

Insider Transaction Report

Form 4
Period: 2022-01-19
FINE N SCOTT
Director
Transactions
  • Purchase

    Common Stock

    2022-01-19$3.89/sh+5,000$19,450134,666 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.87 to $3.89, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4